Saxagliptin is an incretin mimetic drug found in the prescription medications Kombiglyze XR and Onglyza and is used for treating type 2 diabetes.
However, these diabetes drugs have been associated with a potential risk of pancreatic cancer.
Researchers have conducted studies on patients who were taking an incretin mimetic, and they have found strong evidence of pancreatitis and pre-cancerous pancreatic tumors.
Although evidence linking these newer diabetes medications and pancreatic cancer has been growing for many years, concerns have been raised that many patients are not aware of the risks of Kombiglyze XR or other diabetes medication and pancreatic cancer.
What is Kombiglyze XR?
Kombiglyze XR contains a combination of metformin and saxagliptin, oral diabetes medications that help maintain blood sugar levels in patients who have type 2 diabetes.
Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose in the intestinal tract. Saxagliptin works by regulating insulin levels the body produces after eating.
Kombiglyze XR is manufactured by Bristol-Myers Squibb (BMS), and marketed in a joint partnership between BMS and AstraZeneca Pharmaceuticals LP.
Kombiglyze XR Side Effects
Kombiglyze XR is an incretin mimetic diabetes drug, and belongs to a class of diabetes medications that along with pancreatic cancer has recently been linked to the following serious side effects:
- Thyroid Cancer
- Pancreatitis
- Acute Pancreatitis
- Hemorrhagic Pancreatitis
- Necrotizing Pancreatitis
- Kidney Complications
- Renal Failure
- Heart Failure
Kombiglyze XR and Pancreatic Cancer
In March 2013, the FDA launched an investigation into the link between incretin mimetics like Kombiglyze XR and Onglyza and pancreatic cancer. The investigation was initiated after the results of a study published in the medical journal Diabetes identified pre-cancerous cellular changes in pancreatic tissue taken from type 2 diabetics treated with this class of diabetes medications.
Another study conducted by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) and released on June 2013 also investigated the link between incretin mimetics like Kombiglyze XR and pancreatic cancer.
These studies associated Kombiglyze XR with a potential risk of pancreatitis, which is a major risk factor for pancreatic cancer. Other drugs in the same class as Kombiglyze XR have been associated with dozens of reports of pancreatic cancer in the FDA adverse event database, and the FDA has warned about “pre-cancerous cellular changes” in the pancreas of patients taking Kombiglyze XR or similar drugs.
According to an April 2013 report issued by the Institute for Safe Medication Practices (ISMP), more than 100 cases of pancreatic cancer in incretin mimetic users were reported to the FDA during the 12 month period ending in June 2012.
If you or a loved one was diagnosed with pancreatic cancer after taking Kombiglyze XR or another diabetes medication, you may be entitled to compensation and should consider filing a diabetes medication lawsuit. An experienced Kombiglyze XR attorney can help explain your legal options.
In general, Onglyza lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Onglyza lawsuit or Ongylyza class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Onglyza Lawsuit Investigation
If you or a loved one were injured from Onglyza side effects such as heart failure, thyroid cancer or pancreatic cancer, you may have a legal claim. See if you qualify to pursue compensation and join a free Onglyza lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which diabetes drug did you/your loved one take?*
- Onglyza
- Kombiglyze XR
- Other (please describe in additional details box below)
- What year did you/your loved one start taking this medication?*
- Which of the following problems did you/your loved one experience after taking this medication?*
-
Heart Failure
-
Heart Attack
-
Pancreatic Cancer
-
Thyroid Cancer
-
Death
-
Other (please describe in the additional details box below)
-
- What year were you/your loved one diagnosed with one or more of these problems?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 141) {gformInitChosenFields(‘#input_141_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_141_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_141_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [141, 1]) } );
The post Diabetes Drug Kombiglyze XR Linked to Pancreatic Cancer appeared first on Top Class Actions.
No comments:
Post a Comment